Barta O, Huang L J, Pourciau S S, Shaffer L M
Vet Immunol Immunopathol. 1987 Apr;14(4):319-34. doi: 10.1016/0165-2427(87)90035-3.
Numerous infectious and noninfectious diseases are associated with the appearance of suppressive serum lymphocyte immunoregulatory factors (SLIFs). The suppressive SLIFs in sera from clinically healthy dogs and from dogs with bacterial (staphylococcal, brucellar) or mycotic (blastomycotic) infections were further characterized by dialysis, fractionation by ultrafiltrations and HPLC (high performance liquid chromatography) sieving, by affinity chromatography on protein A-Sepharose columns, and by DEAE-cellulose ion exchange chromatography. Factors of various molecular weights and of various elution patterns from DEAE-cellulose and affinity chromatography columns were taking part in the suppressive action of the whole serum. The 'common' inhibitors present in all sera were in the molecular weight range of 28 to 35 Kd, whereas the disease-induced suppressive SLIFs were present in various molecular weight categories. 'Common' suppressor SLIFs and some SLIFs from dogs with staphylococcal infections were partially dialysable; suppressive SLIFs induced in dogs with generalized brucellosis and blastomycosis were not dialysable. Protein A bound suppressive SLIFs from two of three dogs with staphylococcal pyodermas. DEAE-cellulose chromatography gave variable elution patterns with different animal sera. It is concluded that various suppressive SLIFs contribute to the immunosuppressive effect of the whole serum and no disease-specific suppressive SLIF could be identified.
许多传染性和非传染性疾病都与抑制性血清淋巴细胞免疫调节因子(SLIFs)的出现有关。通过透析、超滤分级和高效液相色谱(HPLC)筛分、蛋白A-琼脂糖柱亲和色谱以及DEAE-纤维素离子交换色谱,对临床健康犬以及患有细菌(葡萄球菌、布鲁氏菌)或真菌(芽生菌)感染犬的血清中的抑制性SLIFs进行了进一步表征。来自DEAE-纤维素和亲和色谱柱的具有不同分子量和洗脱模式的因子参与了全血清的抑制作用。所有血清中存在的“常见”抑制剂分子量范围为28至35 kDa,而疾病诱导的抑制性SLIFs存在于各种分子量类别中。“常见”抑制性SLIFs和来自患有葡萄球菌感染犬的一些SLIFs部分可透析;患有全身性布鲁氏菌病和芽生菌病犬诱导产生的抑制性SLIFs不可透析。蛋白A结合了三只患有葡萄球菌性脓皮病犬中两只犬的抑制性SLIFs。DEAE-纤维素色谱对不同动物血清给出了可变的洗脱模式。得出的结论是,各种抑制性SLIFs促成了全血清的免疫抑制作用,且未鉴定出疾病特异性的抑制性SLIF。